arrow
Z

Zhuoming Liu

Washington University School of Medicine
H指数:40
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Practicing community-based research in GIScience and geography – a case study with an Indigenous community, best practices, challenges, and lessons learned

在GIScience和地理学中实践基于社区的研究——一项与Indigenous社区的合作案例研究,最佳实践、挑战与经验总结

2025-08-280
PRE
Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies
2025-01-230
OAAI
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
Nature
IF48.5
2024-05-150
PRE
A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection

靶向SARS-CoV-2刺突N端结构域的广泛反应性抗体赋予Fc介导的保护作用

2023-12-014
OAAI
SARS-CoV-2 requires acidic pH to infect cells
2022-09-0162
OAAI
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice
2022-05-2580
OAAI
Defining the risk of SARS-CoV-2 variants on immune protection
Nature
IF48.5
2022-03-310
PRE
Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time

Sputnik V疫苗接种后的纵向研究表明,随着时间的推移,持久的SARS-CoV-2中和抗体和减少的病毒变异逃逸到中和

MBIO
IF4.7
2022-02-2218
OAAI
JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis
MBIO
IF4.7
2022-02-228
OAAI
Germinal centre-driven maturation of B cell response to mRNA vaccination
Nature
IF48.5
2022-02-150
PRE
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 A Prospective Cohort Study
2021-11-01248
OA
Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters
MBIO
IF4.7
2021-10-2614
OAAI
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
IMMUNITY
IF26.3
2021-10-0175
OAAI